Dr. Katrin Andreasson's group is investigating the role that innate immune responses play in the initiation and progression of neurological diseases. Recent advances in human genetics, particularly for neurodegenerative disorders like Alzheimer’s disease, have highlighted a causal role for a disrupted immune response in disease pathogenesis. An injurious immune response may be a common denominator across many neurological disorders, both acute (brain trauma or stroke) and chronic (epilepsy, Parkinson’s disease, Alzheimer's for eg.).

Dr. Moler's laboratory builds and operates tools for measuring magnetic fields on small length scales.

The overall goal of Dr. Sakamoto's laboratory is to understand the molecular regulation of hematopoiesis and how aberrancies result in diseases of hematopoiesis, including leukemia, bone marrow failure, and myeloproliferative disease.

Dr. Katherine Ferrara's laboratory has projects spanning all aspects of image-guided drug delivery. Major areas of interest include the fusion of images between ultrasound, PET, MRI and CT, the development of activatable drug delivery vehicles, and the development of molecularly-targeted drug delivery vehicles. Members of the Ferrara laboratory bring expertise in many areas including biomedical engineering, physics, electrical engineering, chemical engineering, mechanical engineering, computer science, material science, chemistry, and biology.